首页 > 市场调查报告书 > 製药

生物製剂基因治疗学和RNAi 分子标靶治疗学核酸药物

适体市场规模、份额和成长分析（按类型、应用、技术、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1896094

适体市场规模、份额和成长分析（按类型、应用、技术、最终用户和地区划分）－2026-2033年产业预测

Aptamers Market Size, Share, and Growth Analysis, By Type (DNA Aptamers, RNA Aptamers), By Application (Diagnostics, Therapeutics), By Technology, By End-User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球适体市场规模将达到 1.826 亿美元，到 2025 年将达到 2.2 亿美元，到 2033 年将达到 8 亿美元，预测期（2026-2033 年）的复合年增长率为 17.8%。

全球慢性病发病率的上升趋势，以及标靶治疗的日益普及，预计将显着推动适体需求的成长。对早期诊断解决方案的需求以及对创新诊断技术投资的不断增加，将进一步促进市场成长。此外，SELEX技术的进步可望为适体市场的企业拓展更多机会。医疗研发投入的快速成长、基因疗法的日益广泛应用以及人们对适体益处的认识不断提高，预计都将促进市场扩张。然而，半衰期短、替代疗法的出现、接受度有限以及严格的法规环境等挑战可能会抑制市场需求。已开发地区，尤其是美国和加拿大，为适体供应商提供了充满希望的市场机会。

全球适体市场驱动因素

药物递送技术的日益普及主要得益于标靶治疗因其能够最大限度减少非预期副作用而备受全球关注。这些标靶治疗方案的日益普及推动了对适体的需求，适体是开发创新治疗方法的关键材料。随着对推进药物递送方法的投资不断增加，适体市场凭藉其独特的性质和在创建精准治疗方案方面的有效性而经历了显着增长。因此，全球适体市场格局持续演变，其在现代药物解决方案中的作用日益凸显。

限制全球适体市场的因素

全球适体市场面临许多挑战，其中最主要的原因是适体固有的半衰期极短，通常只有几分钟到几小时。这项限制使得适体的实际应用难以确定，并且在维持其稳定性和功能特性方面也面临持续的挑战。这些挑战阻碍了适体潜力的充分发挥，进而影响了市场需求。儘管人们一直在努力克服这些挑战，但适体有限的寿命仍然是限制其在各个领域广泛应用的重要因素，这最终可能会影响市场的成长轨迹。

全球适体市场趋势

全球适体市场的一大趋势是透过创新化学修饰来增强其稳定性。供应商正致力于聚乙二醇化（PEGylation）和锁核酸（LNA）修饰等技术，这些技术不仅能改善药物动力学，还能优化标靶结合併最大限度地减少在生物系统中的降解。这项转变正在拓宽适体的应用范围，使其在治疗和诊断应用上更加多样化。因此，在适体工程技术的进步推动下，市场有望实现成长，这些进步有望克服现有治疗方法的局限性，并拓展效用。

诊断试剂
- 生物标记检测
- 病原体检测
- 造影
- 伴随诊断
治疗药物
- 肿瘤学
- 心血管疾病
- 感染疾病
- 眼科
- 发炎/自体免疫疾病
研究与开发
- 分子探针
- 目标检验
- 蛋白质相互作用研究
生物感测器
- 环境监测
- 食品安全
- 生物防御应用
药物输送系统
- 精准投放
- 缓释性

全球适体市场规模（依技术及复合年增长率划分）（2026-2033 年）

SELEX
- 常规SELEX
- 细胞筛选
- 毛细管电泳 SELEX
- 微流体SELEX
- 高通量SELEX
SELEX后优化技术
- 化学改性
- 断开
- 二聚化
- 聚乙二醇化

全球适体市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

製药和生物技术公司
学术和研究机构
临床检查室
受託研究机构（CRO）
诊断检查室

全球适体市场规模（依地区划分）及复合年增长率（2026-2033）

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Aptamer Group（UK）
Aptadel Therapeutics（USA）
SomaLogic Operating Co., Inc.（USA）
Base Pair Biotechnologies（USA）
Vivonics, Inc.（USA）
Aptagen, LLC（USA）
Aptus Biotech（Spain）
TriLink BioTechnologies（USA）
AM Biotechnologies, LLC（USA）
Maravai LifeSciences（USA）

结论与建议

简介目录

Product Code: SQMIG35E2038

Global Aptamers Market size was valued at USD 0.1826 Billion in 2024 and is poised to grow from USD 0.22 Billion in 2025 to USD 0.8 Billion by 2033, growing at a CAGR of 17.8% during the forecast period (2026-2033).

The increasing prevalence of chronic diseases globally, coupled with the rising adoption of targeted therapies, is set to significantly boost the demand for aptamers. The need for early diagnostic solutions and heightened investment in innovative diagnostic technologies will further enhance market growth. Additionally, advancements in SELEX technology are poised to broaden the opportunities for aptamer market players. A surge in medical research and development investments, along with the growing utilization of genetic therapies and heightened awareness of aptamer benefits, will contribute to market expansion. However, challenges such as short half-lives, alternative solutions, limited acceptance, and stringent regulatory environments may impede demand. Notably, developed regions like the United States and Canada present promising market opportunities for aptamer providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Aptamers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Aptamers Market Segments Analysis

Global Aptamers Market is segmented by Type, Application, Technology, End-User and region. Based on Type, the market is segmented into DNA Aptamers, RNA Aptamers, XNA Aptamers, Peptide Aptamers and Aptamer-drug conjugates (ApDCs). Based on Application, the market is segmented into Diagnostics, Therapeutics, Research & Development, Biosensors and Drug Delivery Systems. Based on Technology, the market is segmented into SELEX and Post-SELEX Optimization Techniques. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Clinical Laboratories,Contract Research Organizations(CROs) and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Aptamers Market

The expanding focus on drug delivery technology has significantly fueled the emergence of targeted therapeutics, gaining traction globally due to their ability to minimize unforeseen side effects. This rising acceptance of targeted treatment solutions is propelling demand for aptamers, which are integral to the development of these innovative therapies. As more investments flow into the advancement of drug delivery methods, the market for aptamers is witnessing substantial growth, driven by their unique properties and effectiveness in creating precise therapeutic options. Consequently, the global landscape for aptamers is evolving, reinforcing their role in modern pharmaceutical solutions.

Restraints in the Global Aptamers Market

The Global Aptamers market faces significant challenges due to the inherently short half-life of aptamers, typically lasting only minutes to hours. This limitation complicates the identification of practical applications, as maintaining their stability and functional properties without degradation is a persistent difficulty. Such challenges hinder the ability to fully leverage the potential of aptamers, consequently impacting their market demand. As efforts continue to overcome these issues, the restricted lifespan of aptamers remains a critical factor that could impede their widespread adoption and utilization in various fields, ultimately influencing the growth trajectory of the market.

Market Trends of the Global Aptamers Market

The global aptamers market is witnessing a significant trend towards the enhancement of aptamer stability through innovative chemical modifications. Providers are increasingly focusing on techniques like PEGylation and locked nucleic acid (LNA) modifications, which not only improve pharmacokinetics but also optimize target binding and minimize degradation in biological systems. This shift is expanding the application scope of aptamers, making them more versatile for therapeutic and diagnostic uses. As a result, the market is poised for growth, driven by advancements in aptamer engineering that promise to address limitations in existing modalities and broaden their utility across various biomedical fields.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies
Regulatory Landscape

Global Aptamers Market Size by Type & CAGR (2026-2033)

Market Overview
DNA Aptamers
RNA Aptamers
XNA Aptamers
Peptide Aptamers
Aptamer-drug conjugates (ApDCs)

Global Aptamers Market Size by Application & CAGR (2026-2033)

Market Overview
Diagnostics
- Biomarker Detection
- Pathogen Detection
- Imaging Agents
- Companion Diagnostics
Therapeutics
- Oncology
- Cardiovascular Diseases
- Infectious Diseases
- Ophthalmology
- Inflammatory & Autoimmune Diseases
Research & Development
- Molecular Probes
- Target Validation
- Protein Interaction Studies
Biosensors
- Environmental Monitoring
- Food Safety
- Biodefense Applications
Drug Delivery Systems
- Targeted Delivery
- Controlled Release Formulations

Global Aptamers Market Size by Technology & CAGR (2026-2033)

Market Overview
SELEX
- Conventional SELEX
- Cell-SELEX
- Capillary Electrophoresis SELEX
- Microfluidic SELEX
- High-throughput SELEX
Post-SELEX Optimization Techniques
- Chemical Modifications
- Truncation
- Dimerization
- PEGylation

Global Aptamers Market Size by End-User & CAGR (2026-2033)

Market Overview
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Clinical Laboratories
Contract Research Organizations (CROs)
Diagnostic Laboratories

Global Aptamers Market Size & CAGR (2026-2033)

North America (Type, Application, Technology, End-User)
- US
- Canada
Europe (Type, Application, Technology, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Application, Technology, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Application, Technology, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Application, Technology, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Aptamer Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptadel Therapeutics (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SomaLogic Operating Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Base Pair Biotechnologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vivonics, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptagen, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aptus Biotech (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TriLink BioTechnologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AM Biotechnologies, LLC (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Maravai LifeSciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments